Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 2;7(4):e2173.
doi: 10.1097/GOX.0000000000002173. eCollection 2019 Apr.

Soft-tissue Filler-associated Blindness: A Systematic Review of Case Reports and Case Series

Vandana Chatrath  1   2 , Pooja S Banerjee  3 , Greg J Goodman  4 , Eqram Rahman  5
Affiliations

Soft-tissue Filler-associated Blindness: A Systematic Review of Case Reports and Case Series

Vandana Chatrath et al. Plast Reconstr Surg Glob Open. .

Abstract

Background: With the increase in the use of soft-tissue fillers worldwide, there has been a rise in the serious adverse events such as vascular compromise and blindness. This article aims to review the role of fillers in causing blindness and the association between hyaluronic acid (HA) filler and blindness.

Methods: The Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were used to report this review.

Results: A total of 190 cases of blindness due to soft-tissue fillers were identified, of which 90 (47%) cases were attributed to autologous fat alone, and 53 (28%) cases were caused by HA. The rest of the cases were attributed to collagen, calcium hydroxylapatite, and other fillers.

Conclusions: Autologous fat was the most common filler associated with blindness despite HA fillers being the most commonly used across the globe. However, the blindness caused by other soft-tissue fillers like collagen and calcium hydroxylapatite was represented. It was also evident through the review that the treatment of HA-related blindness was likely to have better outcomes compared with other fillers due to hyaluronidase use.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Flow diagram for study screening, selection, and inclusion.
Fig. 2.
Fig. 2.
Number of blindness cases due to various soft-tissue fillers.
Fig. 3.
Fig. 3.
Percentage of reported filler-associated blindness according to the injection site.
See this image and copyright information in PMC

References

    1. Patzer GL. Improving self-esteem by improving physical attractiveness. J Esthet Dent. 1997;9:44. - PubMed
    1. Beleznay K, Carruthers JD, Humphrey S, et al. Avoiding and treating blindness from fillers: a review of the world literature. Dermatol Surg. 2015;41:1097. - PubMed
    1. Haneke E. Managing complications of fillers: rare and not-so-rare. J Cutan Aesthet Surg. 2015;8:198. - PMC - PubMed
    1. Ferneini EM, Ferneini AM. An overview of vascular adverse events associated with facial soft tissue fillers: recognition, prevention, and treatment. J Oral Maxillofac Surg. 2016;74:1630. - PubMed
    1. Humzah MD, Ataullah S, Chiang C, et al. The treatment of hyaluronic acid aesthetic interventional induced visual loss (AIIVL): a consensus on practical guidance. J Cosmet Dermatol. 2019;18:71. - PMC - PubMed